Overview
Janumet 50 mg/1000 mg Tablets combine two active ingredients: Sitagliptin (50 mg) and Metformin Hydrochloride (1000 mg). This fixed-dose combination is used to manage type 2 diabetes mellitus in adults when diet, exercise, and monotherapy with either agent alone do not provide adequate glycemic control. Sitagliptin enhances the body’s incretin system to promote insulin release, while Metformin reduces hepatic glucose production and improves insulin sensitivity.





